Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

18F-Labeled heptapeptide for VEGF-R angiogenesis imaging

Xia Shao and Morand Piert
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 419;
Xia Shao
1Radiology, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morand Piert
1Radiology, University of Michigan, Ann Arbor, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

    Table 1. Binding of 18F-A7R to 9L Tumor Cells

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-Labeled heptapeptide for VEGF-R angiogenesis imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-Labeled heptapeptide for VEGF-R angiogenesis imaging
Xia Shao, Morand Piert
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 419;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-Labeled heptapeptide for VEGF-R angiogenesis imaging
Xia Shao, Morand Piert
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 419;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

  • 99mTc-Labeled carbonic anhydrase IX (CA IX) inhibitors for molecular imaging of cancer
  • 188Re-SOCTA-Chitosan and hepatoma animal model study
  • 99mTc labeled doxorubicin as a potential radioligand for the early cancer detection and treatment response monitoring
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

New Radiopharmaceuticals-Oncology: Apoptosis, Angiogenesis & Proliferation

  • PET imaging of αvβ3 expression in tumors with 68Ga-labeled mono-, di- and tetrameric RGD peptides
  • Radiosynthesis and preliminary evaluation of [18F]DPA as a small-molecule apoptosis PET tracer
  • Evaluation of N3-18F-FPrT, 18F-FLT and 18F-FMAU as PET probes in a tumor-bearing animal model
Show more New Radiopharmaceuticals-Oncology: Apoptosis, Angiogenesis & Proliferation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire